This massive, multi-year development partnership will generate enormous volumes of clinical trial data across four new products. Regeneron will require robust data management, analytics, and secure collaboration platforms to manage the program and avoid partnership friction, a past issue highlighted by a now-settled lawsuit with Sanofi over information access.
Filing excerpt
On October 1, 2026, Regeneron Pharmaceuticals, Inc. ... and Sanofi ... entered into the Sixth Amendment to the Amended and Restated License and Collaboration Agreement
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
Regions named
sec-8kdataInvestmentGet every 8-K signal for Regeneron and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Regeneron this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/1e9149c8-b39c-488f-8b82-6579d978e1c7 returns this record as JSON. POST /v1/companies/enrich returns every signal for regeneron.com.
{
"signal_id": "1e9149c8-b39c-488f-8b82-6579d978e1c7",
"signal_type": "sec-8k",
"signal_subtype": "dataInvestment",
"detected_at": "2026-10-13T07:05:27.802+00:00",
"company": {
"name": "Regeneron",
"domain": "regeneron.com"
},
"data": {
"detail": "This massive, multi-year development partnership will generate enormous volumes of clinical trial data across four new products. Regeneron will require robust data management, analytics, and secure collaboration platforms to manage the program and avoid partnership friction, a past issue highlighted by a now-settled lawsuit with Sanofi over information access.",
"metrics": {
"timeframe": "immediate",
"dollar_context": "Upfront payment from Sanofi for a co-development and co-commercialization agreement for four new antibody products.",
"dollar_millions": 1000
},
"summary": "Regeneron receives $1B upfront in a new Sanofi deal to co-develop four antibodies, driving data infrastructure needs.",
"excerpts": "On October 1, 2026, Regeneron Pharmaceuticals, Inc. ... and Sanofi ... entered into the Sixth Amendment to the Amended and Restated License and Collaboration Agreement",
"relevance": 0.9,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/872589/000110465926113895/tm2627077d1_8k.htm",
"filing_date": "2026-10-06",
"filing_year": 2026,
"sales_relevance": "Target for data vendors",
"signal_category": "technology",
"regions_mentioned": [
"United States"
],
"technologies_mentioned": [
"Nanobody® VHH therapy"
]
}
}
curl https://signals.autobound.ai/v1/signals/1e9149c8-b39c-488f-8b82-6579d978e1c7 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"regeneron.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.